Shoko Tanaka

693 total citations
35 papers, 596 citations indexed

About

Shoko Tanaka is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Shoko Tanaka has authored 35 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Oncology and 8 papers in Immunology. Recurrent topics in Shoko Tanaka's work include Immunotherapy and Immune Responses (6 papers), Chemical Synthesis and Analysis (4 papers) and Click Chemistry and Applications (4 papers). Shoko Tanaka is often cited by papers focused on Immunotherapy and Immune Responses (6 papers), Chemical Synthesis and Analysis (4 papers) and Click Chemistry and Applications (4 papers). Shoko Tanaka collaborates with scholars based in Japan and United States. Shoko Tanaka's co-authors include Akihiro Hazama, Yasunobu Okada, Emi Maeno, Yuhko Ando‐Akatsuka, Seiji Hayashi, Takahiro Shimizu, Kyogo Itoh, Kenshu Fujiwara, Hidetoshi Kawai and Takanori Suzuki and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Physiology and Chemical Communications.

In The Last Decade

Shoko Tanaka

32 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shoko Tanaka Japan 14 284 175 148 101 68 35 596
Wenshan Zhao China 13 312 1.1× 169 1.0× 181 1.2× 130 1.3× 60 0.9× 19 577
Colin Davis United Kingdom 15 1.1k 4.0× 68 0.4× 106 0.7× 63 0.6× 51 0.8× 17 1.4k
Robert E. West United States 15 371 1.3× 395 2.3× 91 0.6× 65 0.6× 137 2.0× 27 748
Arumugam Muruganandam Canada 13 351 1.2× 135 0.8× 95 0.6× 13 0.1× 26 0.4× 16 866
Massimo D’Amico Italy 17 697 2.5× 63 0.4× 262 1.8× 20 0.2× 59 0.9× 34 1.0k
Marcella Debidda United States 13 488 1.7× 83 0.5× 221 1.5× 38 0.4× 72 1.1× 13 857
Klaus Urbahns Germany 15 283 1.0× 113 0.6× 192 1.3× 15 0.1× 173 2.5× 27 683
Lingling Geng China 14 547 1.9× 88 0.5× 121 0.8× 17 0.2× 24 0.4× 19 884
Mingkun Zhao United States 9 273 1.0× 34 0.2× 45 0.3× 58 0.6× 26 0.4× 11 589
Shirley Campbell Canada 18 461 1.6× 37 0.2× 55 0.4× 19 0.2× 32 0.5× 27 777

Countries citing papers authored by Shoko Tanaka

Since Specialization
Citations

This map shows the geographic impact of Shoko Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shoko Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shoko Tanaka more than expected).

Fields of papers citing papers by Shoko Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shoko Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shoko Tanaka. The network helps show where Shoko Tanaka may publish in the future.

Co-authorship network of co-authors of Shoko Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Shoko Tanaka. A scholar is included among the top collaborators of Shoko Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shoko Tanaka. Shoko Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suzuki, Hiroyuki, Shoko Tanaka, Yasuhiro Ohshima, et al.. (2025). An 211At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanoma. European Journal of Nuclear Medicine and Molecular Imaging. 52(6). 2107–2117. 3 indexed citations
2.
Tanaka, Shoko, et al.. (2024). Integrating QR Code Characteristics into Super-Resolution Method. 315–316. 1 indexed citations
4.
Yuan, Jun‐Hui, Xiaoyang Cheng, Eiji Matsuura, et al.. (2023). Genetic, electrophysiological, and pathological studies on patients with SCN9A‐related pain disorders. Journal of the Peripheral Nervous System. 28(4). 597–607. 4 indexed citations
5.
Kakoi, Hironaga, et al.. (2023). Monitoring the positive conversion of anti-erythrocyte antibodies in blood transfusion donor horses. Journal of Equine Science. 34(2). 47–49.
6.
Ishige, Taichiro, Mio Kikuchi, Hironaga Kakoi, et al.. (2023). Evaluation of parentage testing using single nucleotide polymorphism markers for draft horses in Japan. Animal Science Journal. 94(1). e13854–e13854. 1 indexed citations
7.
Matsumoto, Haruki, Yuya Fujita, Naoki Matsuoka, et al.. (2021). Meningoencephalitis in relapsing polychondritis. Medicine. 100(24). e26315–e26315. 4 indexed citations
8.
Ono, Yuko, Shoko Tanaka, Yuko Maejima, et al.. (2020). Opening of Intermediate Conductance Ca2+-Activated K+ Channels in C2C12 Skeletal Muscle Cells Increases the Myotube Diameter via the Akt/Mammalian Target of Rapamycin Pathway. Journal of Pharmacology and Experimental Therapeutics. 376(3). 454–462. 4 indexed citations
9.
Sato, Kohei, Shoko Tanaka, Kazuki Yamamoto, et al.. (2018). Direct synthesis of N-terminal thiazolidine-containing peptide thioesters from peptide hydrazides. Chemical Communications. 54(66). 9127–9130. 18 indexed citations
10.
Tanaka, Shoko, Yuko Ono, & K. Sakamoto. (2017). DCEBIO facilitates myogenic differentiation via intermediate conductance Ca 2+ activated K + channel activation in C2C12 myoblasts. Journal of Pharmacological Sciences. 133(4). 276–279. 10 indexed citations
11.
Tanaka, Shoko, et al.. (2016). Snail1 expression in human colon cancer DLD-1 cells confers invasive properties without N-cadherin expression. Biochemistry and Biophysics Reports. 8. 120–126. 13 indexed citations
12.
Iwao, Yasunori, Kana Takahashi, Shoko Tanaka, et al.. (2011). A comparative study of glycerin fatty acid ester and magnesium stearate on the dissolution of acetaminophen tablets using the analysis of available surface area. European Journal of Pharmaceutics and Biopharmaceutics. 78(3). 492–498. 23 indexed citations
13.
Tanaka, Shoko, et al.. (2009). A case of multiple nodular pulmonary amyloidosis complicated with Sjoegren's syndrome. The Journal of the Japanese Association for Chest Surgery. 23(6). 875–880. 1 indexed citations
15.
Tanaka, Shoko, Mamoru Harada, Takashi Mine, et al.. (2003). Peptide Vaccination for Patients With Melanoma and Other Types of Cancer Based on Pre-existing Peptide-Specific Cytotoxic T-Lymphocyte Precursors in the Periphery. Journal of Immunotherapy. 26(4). 357–366. 36 indexed citations
16.
Suzuki, Nobuaki, Yoshiaki Maeda, Shoko Tanaka, et al.. (2001). Detection of peptide‐specific cytotoxic T‐lymphocyte precursors used for specific immunotherapy of pancreatic cancer. International Journal of Cancer. 98(1). 45–50. 33 indexed citations
17.
Tanaka, Shoko, Naotake Tsuda, Masaru Sakamoto, et al.. (2000). Expression of Tumor‐rejection Antigens in Gynecologic Cancers. Japanese Journal of Cancer Research. 91(11). 1177–1184. 17 indexed citations
18.
Sasatomi, Teruo, Hideaki Yamana, Shigeki Shichijo, et al.. (2000). Expression of the SART1 tumor-rejection antigens in colorectal cancers. Diseases of the Colon & Rectum. 43(12). 1754–1758. 17 indexed citations
19.
Hazama, Akihiro, Iskandar F. Abdullaev, Emi Maeno, et al.. (2000). Swelling‐activated, cystic fibrosis transmembrane conductance regulator‐augmented ATP release and Cl conductances in murine C127 cells. The Journal of Physiology. 523(1). 1–11. 74 indexed citations
20.
Irie, Hiroshi, Shoko Tanaka, Yong Zhang, et al.. (1988). Synthesis of Methoxyonychine and Use of <SUP>1</SUP>H- and <SUP>13</SUP>C-Nuclear Magnetic Resonance Spectra for Structure Determination of Geometrical Isomers of Indan-1-one Oxime Derivatives. Chemical and Pharmaceutical Bulletin. 36(8). 3134–3137. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026